Fundoplication denied as experimental or investigational by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for fundoplication are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Fundoplication as "Experimental" — and Why That Denial Is Highly Appealable

Fundoplication has been performed for decades and is addressed in the clinical guidelines of major gastroenterological and surgical professional societies. A denial characterizing it as "experimental" or "investigational" from BCBS is typically based on one of three things: (1) a specific technique variant (such as a newer endoscopic or robotic approach) that BCBS has not yet reviewed and approved in its coverage policy; (2) an indication outside the standard GERD diagnosis; or (3) an outdated coverage policy that has not been reconciled with current clinical practice. Each of these has a distinct appeal pathway.

## Why This Denial Is Frequently Overturned

For traditional laparoscopic fundoplication performed for documented GERD that has failed adequate medical management, an "experimental" denial is very difficult for BCBS to defend at external review. Independent Review Organizations evaluating such denials apply a standard of whether the procedure is consistent with generally accepted clinical practice — and fundoplication for refractory GERD has substantial support in that regard. If a newer technique is at issue, the appeal should establish that the specific approach used is consistent with the applicable professional society guidelines.

## Federal Appeal Framework

• Internal appeal — File within the timeframe on your Explanation of Benefits (commonly 180 days). Under ERISA §503, request the full clinical basis for the experimental classification, including any technology assessment or coverage policy document BCBS relied on.
• ACA §2719 external review — External review is particularly powerful for experimental/investigational denials because an IRO must assess whether the denial is consistent with generally accepted clinical practice, not just BCBS's internal policy. Confirm the exact deadline on your denial letter; the standard window is approximately four months.
• Expedited review — Available if the delay would seriously jeopardize your health; typically resolved within 72 hours.

## Documentation to Gather

• Surgeon or gastroenterologist letter — A detailed medical-necessity letter citing the applicable professional society guidelines (generically, e.g., "the relevant society guidelines support fundoplication for this indication") and confirming that the specific technique used is consistent with current clinical practice.
• Treatment failure history — Dates, medications, and documented outcomes of prior medical management, establishing that conservative therapy was inadequate.
• Diagnostic workup — Endoscopy, pH study, manometry, or other relevant results referenced by the treating physician to confirm the diagnosis and clinical severity.
• BCBS technology assessment — Request the specific document or clinical policy BCBS used to classify the procedure as experimental; this is required to be disclosed under ERISA §503.
• Professional society guidelines — Generic reference to the relevant guideline organization's position on fundoplication for your indication (do not cite specific page numbers or statistics; reference the organization by name).

## Criteria-Mapping Structure

| BCBS Experimental Classification Basis | Evidence Rebutting Each Basis | |---|---| | Specific technique classified as investigational | Surgeon letter citing professional society support for technique | | Indication outside policy coverage | Diagnosis confirmation + treatment failure documentation | | Outdated coverage policy | Current guideline organization reference | | Each additional criterion in the denial | Specific chart or literature reference from your clinician |